Literature DB >> 7798981

Extrapyramidalism in Alzheimer's disease: prevalence, psychiatric, and neuropsychological correlates.

M Merello1, L Sabe, A Teson, R Migliorelli, M Petracchi, R Leiguarda, S Starkstein.   

Abstract

The prevalence and clinical correlates of extrapyramidal signs in a consecutive series of 78 patients with Alzheimer's disease attending a neurology clinic, and 20 age comparable normal controls, were examined. Based on the unified Parkinson's disease rating scale (UPDRS) findings, 18 patients (23%) met criteria for parkinsonism, 44 (56%) had isolated extrapyramidal signs, and 16 (21%) had no extrapyramidal signs. Whereas the control group showed a similar prevalence of isolated extrapyramidal signs (57%), none of them showed parkinsonism. No significant differences were found for age, sex, duration of illness, and severity of dementia among the three Alzheimer's disease groups. Patients with Alzheimer's disease-parkinsonism, however, showed a significantly higher frequency of major depression and dysthymia and significantly higher Hamilton depression scores than patients with isolated or no extrapyramidal signs. Patients with Alzheimer's disease-parkinsonism also showed significantly more deficits on frontal lobe related tasks such as the Wisconsin card sorting test, trail making test, and verbal fluency, as well as on tests of constructional praxis and abstract reasoning than patients with Alzheimer's disease but no extrapyramidal signs. In conclusion, the study showed a specific association between Alzheimer's disease and parkinsonism, as well as significant relations between parkinsonism, deficits in executive functions, and depression among patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7798981      PMCID: PMC1073233          DOI: 10.1136/jnnp.57.12.1503

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Normative data and screening power of a shortened version of the Token Test.

Authors:  E De Renzi; P Faglioni
Journal:  Cortex       Date:  1978-03       Impact factor: 4.027

3.  Parkinson's disease in patients with Alzheimer's disease.

Authors:  J Leverenz; S M Sumi
Journal:  Arch Neurol       Date:  1986-07

4.  Critical analysis of the disability in Parkinson's disease.

Authors:  D D Webster
Journal:  Mod Treat       Date:  1968-03

5.  Extrapyramidal signs in Alzheimer's disease.

Authors:  P K Mölsä; R J Marttila; U K Rinne
Journal:  Neurology       Date:  1984-08       Impact factor: 9.910

6.  A modified card sorting test sensitive to frontal lobe defects.

Authors:  H E Nelson
Journal:  Cortex       Date:  1976-12       Impact factor: 4.027

7.  CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia.

Authors:  M Roth; E Tym; C Q Mountjoy; F A Huppert; H Hendrie; S Verma; R Goddard
Journal:  Br J Psychiatry       Date:  1986-12       Impact factor: 9.319

8.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

9.  Heterogeneity in dementia of the Alzheimer type: evidence of subgroups.

Authors:  R Mayeux; Y Stern; S Spanton
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

10.  Parkinson's disease and depression. A critical re-evaluation.

Authors:  A E Taylor; J A Saint-Cyr; A E Lang; F T Kenny
Journal:  Brain       Date:  1986-04       Impact factor: 13.501

View more
  5 in total

Review 1.  Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review.

Authors:  Michal Harciarek; Krzysztof Jodzio
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

2.  Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases.

Authors:  K K Gnanalingham; E J Byrne; A Thornton; M A Sambrook; P Bannister
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

3.  Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.

Authors:  Chukwuemeka S Okereke; Louis Kirby; Dinesh Kumar; Edward I Cullen; Raymond D Pratt; William A Hahne
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

Review 4.  Neurodegenerative dementia and parkinsonism.

Authors:  A Gabelle; F Portet; C Berr; J Touchon
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

5.  Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on.

Authors:  George T Grossberg
Journal:  Curr Ther Res Clin Exp       Date:  2003-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.